Wearables are improving the clinical trial experience for patients and satisfying the need to collect data for real-world use studies.
Experts agree: future drug development will be based on broader, real-time patient data.
Connected health, which includes wearable devices and mobile health (mHealth) technology, is providing the industry with an opportunity for patient-centric data generation.
Currently, about 10% to 15% of trials are incorporating wearable devices, primarily to collect data as exploratory endpoints. But industry experts say there is a push for wearables to be a bigger part of efforts to improve patients’ experience with clinical trials and to collect data for real-world use studies.